Search results for "CLINICAL TRIALS"

showing 10 items of 490 documents

Theory-Based Interventions Combining Mental Simulation and Planning Techniques to Improve Physical Activity: Null Results from Two Randomized Control…

2016

Interventions to assist individuals in initiating and maintaining regular participation in physical activity are not always effective. Psychological and behavioral theories advocate the importance of both motivation and volition in interventions to change health behavior. Interventions adopting self-regulation strategies that foster motivational and volitional components may, therefore, have utility in promoting regular physical activity participation. We tested the efficacy of an intervention adopting motivational (mental simulation) and volitional (implementation intentions) components to promote a regular physical activity in two studies. Study 1 adopted a cluster randomized design in wh…

and promotion of well-being[SHS.EDU]Humanities and Social Sciences/Educationlcsh:BF1-990Clinical Trials and Supportive ActivitiesPsychological intervention[SHS.PSY]Humanities and Social Sciences/Psychologyphysical activity050109 social psychologylaw.inventionmental simulation03 medical and health sciences0302 clinical medicineRandomized controlled trial[SDV.SP.MED]Life Sciences [q-bio]/Pharmaceutical sciences/Medicationhealth behaviorClinical ResearchlawBehaviour change techniquesIntervention (counseling)Behavioral and Social SciencePsychology0501 psychology and cognitive sciences030212 general & internal medicineta315General PsychologyComputingMilieux_MISCELLANEOUSta515Original ResearchVolition (psychology)OperationalizationImplementation intentionPrevention05 social sciencesAttendancePrevention of disease and conditions3. Good healthTest (assessment)implementation intentionlcsh:PsychologyMental HealthGood Health and Well Beingbehavior change interventionHealth behaviour3.1 Primary prevention interventions to modify behaviours or promote wellbeingCognitive Sciences[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiePsychologyClinical psychologyFrontiers in Psychology
researchProduct

Looking for the best immune-checkpoint inhibitor in pre-treated NSCLC patients: An indirect comparison between nivolumab, pembrolizumab and atezolizu…

2017

Immune-checkpoint inhibitors represent the new standard of care in patients with advanced NSCLC who progressed after first-line treatment. This work aim to assess any difference in both efficacy and safety profiles among Nivolumab, Pembrolizumab and Atezolizumab in pre-treated NSCLC patients. Randomized clinical trials comparing immune-checkpoint inhibitor versus docetaxel in pre-treated patients with advanced NSCLC were included and direct comparison meta-analysis of selected trials have been performed. Subsequently the summary estimates of Nivolumab, Pembrolizumab and Atezolizumab emerging from the direct meta-analysis were selected to provide the pooled estimates of hazard ratio (HR) and…

atezolizumabCancer ResearchLung NeoplasmsAntineoplastic AgentsDocetaxelAntibodies Monoclonal HumanizedNSCLCClinical Trials Phase II as TopicCostimulatory and Inhibitory T-Cell ReceptorsCarcinoma Non-Small-Cell LungPDL1HumansRandomized Controlled Trials as TopicnivolumabIncidenceAntibodies MonoclonalPneumoniaSurvival AnalysisPD1Treatment OutcomeClinical Trials Phase III as TopicOncologyimmune-checkpointTaxoidsatezolizumab; immune-checkpoint; nivolumab; NSCLC; PD1; PDL1; pembrolizumab; Oncology; Cancer Researchpembrolizumab
researchProduct

Bempedoic acid as adjunct for traditional lipid-lowering therapy in patients with hyperlipidaemia

2020

Statin therapy has been the cornerstone for the reduction of cholesterol and circulating low-density lipoprotein (LDL) in patients with cardiovascular diseases. However, statin monotherapy has disadvantages attributable to myopathies and to the insufficient cholesterol reduction observed in some patients. There is a need for new well-tolerated therapies for lowering LDL. This review will focus on bempedoic acid in combination with traditional statin therapy or other lipid-lowering agents and its emerging role in LDL-C lowering. Bempedoic acid is also a viable alternative for reducing LDL cholesterol in the treatment of some patients suffering from heterozygous familial hypercholesterolemia.

bempedoic acidmedicine.medical_specialtyStatinmedicine.drug_classHyperlipidemiasFamilial hypercholesterolemia030204 cardiovascular system & hematologyLipid-lowering therapystatins03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicinemedicineHumansDicarboxylic AcidsIn patient030212 general & internal medicineHypolipidemic AgentsClinical Trials as Topiclipid-lowering therapyCholesterolbusiness.industryFatty Acidsnutritional and metabolic diseasesCholesterol LDLGeneral Medicinemedicine.diseaselow-density lipoproteinchemistryDrug Therapy Combinationlipids (amino acids peptides and proteins)Statin therapyHydroxymethylglutaryl-CoA Reductase InhibitorsatherosclerosisCardiology and Cardiovascular MedicinebusinessBempedoic acidLipoproteinCoronary Artery Disease
researchProduct

Síntomas, signos y estadística: Aplicaciones de la estadística en ciencias de la salud y de la vida

2014

La determinación o constatación experimental de los mecanismos fisiológicos de las enfermedades suele ser una tarea muy compleja. Esto ha convertido a la epidemiología en la principal herramienta de generación de conocimiento en el ámbito médico. La epidemiología aprende sobre las enfermedades a partir de la observación de la salud en colectivos de personas, en lugar de la observación individual de éstas. Si la principal herramienta de generación de conocimiento médico se basa en la observación de colectivos de personas (muestras de una población) de las que querremos aprender (hacer inferencia), resulta claro el nexo entre la estadística y la medicina. A lo largo de este artículo ilustramo…

clinical trialssupervivenciabioestadística; ciencias de la salud y de la vida; ensayos clínicos; epidemiología; supervivenciastatistics; computer scienceciències de la salut i de la vidabiostatisticscomputer scienceciencias de la salud y de la vidasurvivalbiostatistics; health and life sciences; clinical trials; epidemiology; survivalestadísticaestadística; medicinabioestadísticastatisticsensayos clínicosassajos clínicsbioestadística; ciències de la salut i de la vida; assajos clínics; epidemiologia; supervivènciahealth and life sciencesepidemiologyepidemiologiasupervivènciamedicinaepidemiología
researchProduct

Pharmacological treatment of burning mouth syndrome : a review and update

2007

Burning mouth syndrome (BMS) is defined as a burning sensation in the tongue or in any other region of the oral mucosa, in the absence of specific oral lesions. The present study reviews the pharmacological treatments used in the last 10 years to reduce the symptoms of BMS, and assesses the efficacy and safety of pharmacological interventions destined to alleviate the symptoms of BMS. To this effect, searches were made in the following databases: Micromedex®, Cochrane Database® and PubMed®, crossing the following key words: drug, treatment, clinical trial, pain management, and burning mouth syndrome. The searches were limited to articles published in the last 10 years in English or Spanish,…

clinical trialstreatmentantidepresivoseducationdigestive oral and skin physiologyBurning mouth syndrome:CIENCIAS MÉDICAS [UNESCO]stomatognathic diseasestratamientoanalgésicosantidepressantsensayos clínicosUNESCO::CIENCIAS MÉDICASanalgesicscasos clínicosclinical casesSíndrome de boca ardiente
researchProduct

Lonoctocog alfa (rVIII-SingleChain) for the treatment of haemophilia A

2017

Introduction: The administration of factor VIII (FVIII) concentrates on-demand or on long-term prophylaxis is the effective and safe standard of care of patients with hemophilia A (HA). Development of neutralizing antibodies against exogenous FVIII and the short half-life of the current available products remain major challenges. There is currently a great interest towards newer FVIII products with the goal of reducing the inhibitor risk and increasing the half-life. Area covered: In this review, the authors describe the efficacy and safety of rVIII-SingleChain (Lonoctocog alfa), the first and only single chain recombinant FVIII (rFVIII) molecule developed for the prevention and treatment o…

congenital hereditary and neonatal diseases and abnormalitiesPediatricsmedicine.medical_specialtyHaemophiliaStandard of caresingle-chainHaemophilia AClinical BiochemistrySingle chain030204 cardiovascular system & hematologyHaemophiliaHemophilia A03 medical and health sciences0302 clinical medicineLONOCTOCOG ALFAhemic and lymphatic diseasesDrug DiscoverymedicineHumansPharmacologyClinical Trials as TopicFactor VIIIbusiness.industryCoagulantsDrug Discovery3003 Pharmaceutical ScienceRecombinant Proteinmedicine.diseaseRecombinant ProteinsCoagulantbusiness030215 immunologyHalf-LifeHuman
researchProduct

Scheduling a cellular manufacturing system with GA

2002

The flexible manufacturing cell scheduling problem is considered with a multi-objective approach, pursuing together makespan minimisation and the in process job wait minimisation. The formulation of the scheduling problem is discussed, analysing how to generate well suited sequences, like generalised permutation sequences, and the proper construction of a JIT timing of activities. An evolutionary sequencing algorithm based on both classic genetic operators and hybrid operators is then proposed. The hybrid operators have been introduced to construct highly fit initial population, to perform periodically a local search on the population and to maintain enough genetical diversity in the actual…

education.field_of_studyMathematical optimizationScheduleJob shop schedulingbusiness.industryComputer scienceCellular manufacturingPopulationScheduling (production processes)Work in processHybrid algorithmMinimisation (clinical trials)Scheduling (computing)Production controlGenetic algorithmLocal search (optimization)businesseducation
researchProduct

Palliative sedation in patients with advanced cancer followed at home: A systematic review

2011

Abstract Context Patients with advanced cancer who are near the end of life may experience intolerable suffering refractory to targeted palliative therapies. Palliative sedation (PS) is considered to be an effective treatment modality for these refractory symptoms when aggressive efforts fail to provide relief. Objectives The aim of this study was to systematically review articles regarding PS performed at home in patients with intractable symptoms. Methods Literature databases searched included MedLine, PubMed, and EMBASE. The text words and MeSH/EMTREE terms "home care" and "sedation" were used for electronic database searches. Results Six articles met the inclusion criteria for research …

end of lifemedicine.medical_specialtyPalliative careSedationMEDLINEPainContext (language use)Palliative sedationend of life; home care; Palliative sedation; Clinical Trials as Topic; Delirium; Dyspnea; Home Care Services; Humans; Hypnotics and Sedatives; Neoplasms; Pain; Retrospective Studies; Treatment Outcome; Palliative Care; Anesthesiology and Pain Medicine; Neurology (clinical); Nursing (all)2901 Nursing (miscellaneous)NeoplasmsmedicineHumansHypnotics and SedativesIntensive care medicineProspective cohort studyGeneral NursingNursing (all)2901 Nursing (miscellaneous)Retrospective StudiesClinical Trials as Topicbusiness.industryPalliative CareDeliriumRetrospective cohort studyHome Care ServicesDyspneaTreatment OutcomeAnesthesiology and Pain MedicineMeta-analysisMidazolamNeurology (clinical)medicine.symptombusinesshome caremedicine.drug
researchProduct

Review article: a comparison of glucagon-like peptides 1 and 2.

2013

Summary Background Recent advancements in understanding the roles and functions of glucagon-like peptide 1 (GLP-1) and 2 (GLP-2) have provided a basis for targeting these peptides in therapeutic strategies. Aim To summarise the preclinical and clinical research supporting the discovery of new therapeutic molecules targeting GLP-1 and GLP-2. Methods This review is based on a comprehensive PubMed search, representing literature published during the past 30 years related to GLP-1 and GLP-2. Results Although produced and secreted together primarily from L cells of the intestine in response to ingestion of nutrients, GLP-1 and GLP-2 exhibit distinctive biological functions that are governed by t…

endocrine systemmedia_common.quotation_subjectIncretinPharmacologyintestinal peptides GLP-1 GLP-2 incretin intestinal motilitySettore BIO/09 - FisiologiaIntestinal mucosaGlucagon-Like Peptide 1Glucagon-Like Peptide 2Receptors GlucagonAnimalsHumansMedicinePharmacology (medical)Molecular Targeted TherapyReceptormedia_commonClinical Trials as TopicHepatologybusiness.industrydigestive oral and skin physiologyGastroenterologyAppetiteReview articleDisease Models Animalmedicine.anatomical_structureGlucagon-Like PeptidesbusinessPancreashormones hormone substitutes and hormone antagonistsFunction (biology)
researchProduct

Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome

2008

BACKGROUND: Ovarian hyperstimulation syndrome (OHSS) typically occurs when ovaries are primed with FSH/ LH and subsequently exposed to hCG. The ultimate pathophysiological step underlying this clinical picture is increased vascular permeability (VP). METHODS: A search of the literature was carried out using PubMed and the authors’ files. RESULTS: In rodents and humans, the expression of vascular endothelial growth factor (VEGF) and VEGF receptor 2 (VEGFR-2) mRNA increases during ovarian stimulation. With the administration of hCG, the expression of each rises to a maximum. Expression of VEGF/VEGFR-2 mRNAs correlates with enhanced VP, with both peaking 48 h following an injection of hCG. Imm…

endocrine systemmedicine.medical_specialtyCabergolineIndolesOvarian hyperstimulation syndromeVascular permeabilityBiologyChorionic GonadotropinDopamine agonistCapillary PermeabilityOvarian Hyperstimulation Syndromechemistry.chemical_compoundInternal medicineCabergolinemedicineAnimalsHumansPyrrolesErgolinesPhosphorylationCells CulturedClinical Trials as TopicEstradiolVascular Endothelial Growth FactorsObstetrics and GynecologyEstrogensKinase insert domain receptormedicine.diseaseRatsVascular endothelial growth factorActin CytoskeletonVascular endothelial growth factor Amedicine.anatomical_structureEndocrinologyReproductive MedicinechemistryDopamine AgonistsReproductive Control AgentsFemaleCorpus luteumSignal Transductionmedicine.drugHuman Reproduction Update
researchProduct